Samjin Pharmaceuticals Co., Ltd. (KRX:005500)
South Korea · Delayed Price · Currency is KRW 20,100
+300 (1.52%)
At close: Nov 26, 2025
Samjin Pharmaceuticals Market Cap
Samjin Pharmaceuticals has a market cap or net worth of 246.38 billion as of November 26, 2025. Its market cap has increased by 5.62% in one year.
Market Cap
246.38B
Enterprise Value
n/a
Revenue
274.03B
Ranking
n/a
PE Ratio
11.63
Stock Price
20,100.00
Market Cap Chart
Since August 30, 1995, Samjin Pharmaceuticals's market cap has increased from 29.12B to 246.38B, an increase of 746.10%. That is a compound annual growth rate of 7.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 246.38B | 11.18% |
| Dec 30, 2024 | 221.61B | -19.69% |
| Dec 28, 2023 | 275.94B | -19.80% |
| Dec 29, 2022 | 344.07B | 5.06% |
| Dec 30, 2021 | 327.51B | -3.49% |
| Dec 30, 2020 | 339.34B | 9.22% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 41.00T |
| ALTEOGEN | 28.93T |
| SK Biopharmaceuticals | 9.91T |
| ABL Bio | 9.86T |
| Yuhan | 8.73T |
| Peptron | 8.60T |
| LigaChem Biosciences | 6.49T |